10:15 - 13.00

3^rd session:
Pharmaco-Surgery and beyond

Chairmen and moderation:
Lars Olof Hattenbach (Ludwigshafen)
Einar Stefánsson (Reykjavík)

Jörg Christian Schmidt (Marburg)
Development of collateral vessels under Avastin® –
Therapy for branch retinal vein occlusion

Stephen H. Sinclair (Media)
Effect on High Contrast Discriminated Target Central Fields
of Avastin Monotherapy for CNVM due to AMD

Paul E. Tornambe (San Diego)
A prospective non randomized trial with one year follow up c
omparing Avastin to Lucentis for exudative AMD

Paul B. Griggs for the RVT Investigator Group (Seattle)
Combination Therapy of CNV Caused By AMD with Verteporfin
PDT and Bevacizumab: The Registry of Visudyne® AMD Therapy
Database

Einar Stefánsson (Reykjavík)
Ocular drug delivery: Eyedrops with Nanoparticles with dexamethasone and cylodextrin that deliver steroids to the rabbit retina in significant concentration

Michael T. Trese (Royal Oak)
Pharmacologis Vitreodynamics: What Is It? – Why Is It Important?

Carsten H. Meyer (Bonn)
“Computer-moritoring“ – what is possible?

Michael Janusz Koss (Frankfurt/Main)
Rheopheresis – update 2007

Torsten Kühn (Novartis Pharma GmbH)
In silico study

Reinhard Klingel (Apherese Forschungs-Institut GmbH)
Interdisciplinäre Qualitätssicherung der Rheopherese

Peter Luloh (Insight Instruments, Inc.)
Intrector®

Lunch and coffee break in the industrial exhibition area
AMO and Alcon invite you for this coffee break.

14:00 - 15.00

Panel discussion with all session speakers

Panel moderator:
Giampaolo Gini (Prato)
Einar Stefánsson (Reykjavík)